We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
135 hedge funds and large institutions have $664M invested in Corcept Therapeutics in 2017 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 37 increasing their positions, 52 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
779% more call options, than puts
Call options by funds: $1.97M | Put options by funds: $224K
71% more capital invested
Capital invested by funds: $387M → $664M (+$277M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
27% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 22
5.64% more ownership
Funds ownership: 48.05% → 53.69% (+5.6%)
0% more funds holding
Funds holding: 135 → 135 (0)
29% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 52
Holders
135
Holders Change
–
Holders Change %
0%
% of All Funds
3.36%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
28
Increased
37
Reduced
52
Closed
22
Calls
$1.97M
Puts
$224K
Net Calls
+$1.75M
Net Calls Change
+$858K
Top Buyers
| 1 |
BlackRock
New York
|
+$60.4M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$45.4M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$6.56M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$5.97M |
| 5 |
Bank of New York Mellon
New York
|
+$3.81M |
Top Sellers
| 1 |
IA
Investor AB
Stockholm,
Sweden
|
-$5.49M |
| 2 |
Two Sigma Investments
New York
|
-$3.78M |
| 3 |
Morgan Stanley
New York
|
-$2.98M |
| 4 |
ISL
Ingalls & Snyder LLC
New York
|
-$2.78M |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$1.8M |
